PER977 reduced whole-blood clotting time significantly more rapidly than in controls among healthy persons who had received a single dose of edoxaban.
Does PER977 reduce whole-blood clotting time in healthy persons who received a single dose of edoxaban?
PER977 significantly accelerates the reversal of edoxaban-induced anticoagulation as measured by whole-blood clotting time.
Tasa de eventos absoluta: 0% vs 0%
Among 80 healthy persons who had received a single dose of edoxaban, the whole-blood clotting time was reduced significantly more rapidly in those who received the novel small molecule PER977 than in controls who were not given PER977.
Ansell et al. (Wed,) reported a other. PER977 reduced whole-blood clotting time significantly more rapidly than in controls among healthy persons who had received a single dose of edoxaban.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: